Renal Biomarkers Global Market Report 2025

Global Renal Biomarkers Market Report 2025

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Renal Biomarkers Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Renal Biomarkers Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Renal Biomarkers Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Renal Biomarkers Market?

Renal biomarker refers to proteins, lipids, genes, metabolites, proteomic patterns, or cells that are found on a urinalysis that is employed to determine the glomerular filtration rate of the kidney, a drop in which indicates kidney damage. The renal biomarkers are used to estimate the nature and severity of kidney injury.

The main types of biomarkers in renal biomarkers are functional biomarker, upregulated protein, and other biomarker types. Functional biomarkers refer to the biomarker that allows the diagnosis of kidney injury in individuals with normal kidney function, also in chronic kidney disease patients where the same injury would give rise to a significant decrease in functional biomarkers such as Cr. The different diagnostic techniques include Enzyme-Linked Immunosorbent Assay, particle-enhanced turbidimbiometric immunoassay (PETIA), colorimetric assay, and chemiluminescent enzyme immunoassay (CLIA), liquid chromatography-mass spectrometry (LS-MS). The applications include diagnosis and disease progression monitoring and research homecare and are used by hospitals, diagnostic laboratories, and other end users.

Renal Biomarkers Market Size and growth rate 2025 to 2029: Graph

What Is The Renal Biomarkers Market Size 2025 And Growth Rate?

The renal biomarkers market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases.

What Is The Renal Biomarkers Market Growth Forecast?

The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to personalized medicine and targetedTherapies, integration of biomarker testing into routine clinical practice, emerging markets in asia and latin america, non-invasive biomarker testing methods, continuous monitoring with wearable devices. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, AI and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention.

Book your 30 minutes free consultation with our research experts

How Is The Renal Biomarkers Market Segmented?

The renal biomarkers market covered in this report is segmented –

1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types

2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)

3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare

4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate

2) By Up Regulated Protein: Neutrophil Gelatinase-AsSOCiated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)

3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers

What Is Driving The Renal Biomarkers Market? Rising Demand For Renal Biomarkers Impact Of Geriatric And Pediatric Patients

The rise in geriatric and pediatric renal patients is expected to propel the growth of the renal biomarkers market going forward. Geriatric renal patients refer to the elderly patients aged above 70 years with advanced chronic kidney disease (CKD). However, paediatric renal patients refer to the patients who are commonly diagnosed with renal disorder during childhood and young adulthood. Renal biomarkers help to evaluate the severity of renal injury in geriatric and paediatric renal patients. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic kidney disease (CKD) mortality rates increased by 4.2% in 2021 and 6.2% in 2022. Therefore, the rise in geriatric and paediatric renal patients is driving the growth of the renal biomarkers market.

What Is Driving The Renal Biomarkers Market? Rising Chronic Kidney Disease Incidence Fuels Renal Biomarkers Market Growth

The rising incidence of chronic kidney diseases is expected to propel the growth of the renal biomarkers market going forward. Chronic kidney disease (CKD) is a medical condition characterized by the gradual loss of kidney function over time. Renal biomarkers play a crucial role in identifying and tracking the progression of CKD, facilitating timely intervention and personalized treatment strategies, ultimately improving patient outcomes. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic kidney disease (CKD) mortality rates increased by 4.2% in 2021 and 6.2% in 2022. Therefore, the rising incidence of chronic kidney diseases is driving the growth of the renal biomarkers market.

Who Are The Major Players In The Global Renal Biomarkers Market?

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

What Are The Key Trends Of The Global Renal Biomarkers Market? Innovative Technologies Transforming The Renal Biomarkers Market

Technological advancements have emerged as a key trend gaining popularity in the renal biomarkers market. Major players operating in the renal biomarkers sector is focused on developing innovative technologies to sustain their position in the market. For instance, in March 2022, Nipro Medical Corporation, a US-based medical equipment manufacturing company launched SURDIAL DX. The SURDIAL DX hemodialysis system is a cutting-edge device, featuring advanced technology for optimal patient safety, comfort, and efficiency. It includes state-of-the-art design elements such as streamlined automated processes, ergonomic design, and a commitment to enhancing the overall dialysis treatment experience.

What Are The Key Trends Of The Global Renal Biomarkers Market? Strategic Collaborations To Expand Product Portfolio

Major companies are strategically entering into partnerships and collaborations with start-ups and mid-sized companies in the renal biomarkers market to broaden the products and services offered by the company. Strategic collaborations and partnership agreements help companies expand their existing product portfolio and geographical reach. For instance, in June 2022, Nordic Bioscience, a Denmark based biomarker company, announced the strengthening of its ongoing collaboration with F. Hoffmann-La Roche Ltd., a multinational healthcare company for the development of proprietary biomarkers involved in tissue breakdown and build-up. Under the collaboration, Nordic Bioscience will transfer unique and proprietary blood-based biomarkers to Roche Diagnostics to be implemented on the automated COBAS platform. Nordic Bioscience's (Extracellular Matrix) ECM biomarkers are unique and essential for all chronic diseases involving tissue fibrosis inflammation and kidney diseases. The collaboration will facilitate better clinical decisions in drug development and patient selection as well as enrichment for precision medicine and ultimately improve patient outcomes.

Renal Biomarkers Market Merger And Acquisition: Novartis Acquires SanReno Therapeutics, Strengthening its Focus on Kidney Disease Therapies

In January2024, Novartis AG, a Switzerland-based pharmaceutical company, acquired SanReno Therapeutics for an undisclosed amount. This rare acquisition of a Chinese biotech by a multinational highlights China's potential in the global renal market and aligns with Novartis' focus on innovative kidney disease therapies. SanReno Therapeutics is a China-based biopharma company specializes in renal disease therapies.

Regional Outlook For The Global Renal Biomarkers Market

North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the renal biomarkers market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Renal Biomarkers Market?

The renal biomarker market consists of revenues earned by entities by providing renal biomarker services such as integrated drug discovery, phenotypic assay, custom services, in vivo, biomarker identification, glomerular filtration diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The renal biomarker market also includes sales of point-of-care kit, antibody screening, cell-based diagnostic devices which are used in providing renal biomarker services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Renal Biomarkers Industry?

The renal biomarker market research report is one of a series of new reports from The Business Research Company that provides renal biomarker market statistics, including renal biomarker industry global market size, regional shares, competitors with a renal biomarker market share, detailed renal biomarker market segments, market trends and opportunities, and any further data you may need to thrive in the renal biomarker industry. This renal biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Renal Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.38 billion
Revenue Forecast In 2034	$1.91 billion
Growth Rate	CAGR of 8.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types 2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS) 3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare 4) By End User: Hospitals, Diagnostic Laboratories, Other End Users Subsegments: 1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate 2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18) 3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Renal Biomarkers Market Characteristics

3. Renal Biomarkers Market Trends And Strategies

4. Renal Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Renal Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Renal Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Renal Biomarkers Market Growth Rate Analysis

5.4. Global Renal Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Renal Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Renal Biomarkers Total Addressable Market (TAM)

6. Renal Biomarkers Market Segmentation

6.1. Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Functional Biomarker

Up Regulated Protein

Other Biomarker Types

6.2. Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enzyme-Linked Immunosorbent Assay

Particle-Enhanced Turbidimetric Immunoassay (PETIA)

Colorimetric Assay

Chemiluminescent Enzyme Immunoassay (CLIA)

Liquid Chromatography Mass Spectrometry (LS-MS)

6.3. Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnosis And Disease Progression Monitoring

Research Homecare

6.4. Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Other End Users

6.5. Global Renal Biomarkers Market, Sub-Segmentation Of Functional Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creatinine

Urea

Cystatin C

Bicarbonate

6.6. Global Renal Biomarkers Market, Sub-Segmentation Of Up Regulated Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Kidney Injury Molecule-1 (KIM-1)

Interleukin-18 (IL-18)

6.7. Global Renal Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Proximal Tubule Injury Biomarkers

Acute Kidney Injury Biomarkers

Chronic Kidney Disease Biomarkers

7. Renal Biomarkers Market Regional And Country Analysis

7.1. Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Renal Biomarkers Market

8.1. Asia-Pacific Renal Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Renal Biomarkers Market

9.1. China Renal Biomarkers Market Overview

9.2. China Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Renal Biomarkers Market

10.1. India Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Renal Biomarkers Market

11.1. Japan Renal Biomarkers Market Overview

11.2. Japan Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Renal Biomarkers Market

12.1. Australia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Renal Biomarkers Market

13.1. Indonesia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Renal Biomarkers Market

14.1. South Korea Renal Biomarkers Market Overview

14.2. South Korea Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Renal Biomarkers Market

15.1. Western Europe Renal Biomarkers Market Overview

15.2. Western Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Renal Biomarkers Market

16.1. UK Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Renal Biomarkers Market

17.1. Germany Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Renal Biomarkers Market

18.1. France Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Renal Biomarkers Market

19.1. Italy Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Renal Biomarkers Market

20.1. Spain Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Renal Biomarkers Market

21.1. Eastern Europe Renal Biomarkers Market Overview

21.2. Eastern Europe Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Renal Biomarkers Market

22.1. Russia Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Renal Biomarkers Market

23.1. North America Renal Biomarkers Market Overview

23.2. North America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Renal Biomarkers Market

24.1. USA Renal Biomarkers Market Overview

24.2. USA Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Renal Biomarkers Market

25.1. Canada Renal Biomarkers Market Overview

25.2. Canada Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Renal Biomarkers Market

26.1. South America Renal Biomarkers Market Overview

26.2. South America Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Renal Biomarkers Market

27.1. Brazil Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Renal Biomarkers Market

28.1. Middle East Renal Biomarkers Market Overview

28.2. Middle East Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Renal Biomarkers Market

29.1. Africa Renal Biomarkers Market Overview

29.2. Africa Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Renal Biomarkers Market Competitive Landscape And Company Profiles

30.1. Renal Biomarkers Market Competitive Landscape

30.2. Renal Biomarkers Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. BioPorto Diagnostics A/S Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis

30.2.5. bioMérieux SA Overview, Products and Services, Strategy and Financial Analysis

31. Renal Biomarkers Market Other Major And Innovative Companies

31.1. Randox Laboratories

31.2. Siemens Healthineers

31.3. Beckman Coulter Inc.

31.4. Astute Medical Inc.

31.5. Nexelis Company

31.6. Sphingotec GmbH

31.7. Bio-Rad Laboratories India Pvt. Ltd.

31.8. Enzo Biochem Inc.

31.9. PerkinElmer Inc.

31.10. Novartis AG

31.11. Alere Inc.

31.12. AstraZeneca plc

31.13. Bio-Techne Corp.

31.14. DiaSorin S.p.A.

31.15. EKF Diagnostics Holdings plc

32. Global Renal Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Renal Biomarkers Market

34. Recent Developments In The Renal Biomarkers Market

35. Renal Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Renal Biomarkers Market In 2029 - Countries Offering Most New Opportunities

35.2 Renal Biomarkers Market In 2029 - Segments Offering Most New Opportunities

35.3 Renal Biomarkers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Renal Biomarkers Market, Sub-Segmentation Of Functional Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Renal Biomarkers Market, Sub-Segmentation Of Up Regulated Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Renal Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Abbott Laboratories Financial Performance

Table 79: BioPorto Diagnostics A/S Financial Performance

Table 80: Roche Holding AG Financial Performance

Table 81: Thermo Fisher Scientific Financial Performance

Table 82: bioMérieux SA Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Renal Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Renal Biomarkers Market, Sub-Segmentation Of Functional Biomarker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Renal Biomarkers Market, Sub-Segmentation Of Up Regulated Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Renal Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Renal Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Renal Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Abbott Laboratories Financial Performance

Figure 79: BioPorto Diagnostics A/S Financial Performance

Figure 80: Roche Holding AG Financial Performance

Figure 81: Thermo Fisher Scientific Financial Performance

Figure 82: bioMérieux SA Financial Performance

Growth, Trends, and Opportunities in the ACL Reconstruction Procedures Market: Key Insights for the Next Decade

Key Highlights of the Acute Pancreatitis Market 2025-2034: Growth Dynamics, Trends, and Opportunities

The Road Ahead for the Adenosine Triphosphate (ATP) Assays Market: Key Growth Trends and Opportunities to Watch

Age-Related Macular Degeneration Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

The Road Ahead for the Air Ambulance Services Market: Key Growth Trends and Opportunities to Watch

Amniotic Membrane Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities

Comprehensive Analysis of the Aortic Aneurysm Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Key Drivers and Opportunities in the Autologous Cell Therapy Market: Insights into Trends and Growth

Site Remediation Consulting Services Global Market Report 2025 – By Type (Bioremediation, Pump & treat, In situ vitrification, Thermal treatment, Chemical treatment, Excavation, Soil washing, Other Types), By Service (Remediation Services, Soil Remediation Services, Water Remediation Services), By Application (Waste disposal sites, Oil & gas, Mining, Chemical & Petrochemical, Manufacturing, Agriculture, Construction, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Scientific Research And Development Services Global Market Report 2025 – By Type (Social Sciences And Humanities Services, Physical, Engineering, And Life Sciences, Nanotechnology Services, Biotechnology Services), By Mode (Online, Offline), By End User Size (Large Enterprise, Small and Medium Enterprise) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Psoriasis Global Market Report 2025 – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis), By Route Of Administration (Oral, Tropical, Injectable ), By Distribution Channel (Hospitals, Retail Pharmacies, E-Commerce ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025 – By Product Type (Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices), By Type (Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), By Technology (Biological Valve, Decellularized Valve), By Application (Hospitals, Ambulatory Surgery Centres) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2025-2034

View Report

3D Cell Culture Technologies Global Market Report 2025 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical API Manufacturing Global Market Report 2025 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the renal biomarkers market?

How will the renal biomarkers market drivers and restraints affect the renal biomarkers market dynamics? What forces will shape the renal biomarkers industry going forward?

The renal biomarkers market major growth driver - Rising Demand For Renal Biomarkers Impact Of Geriatric And Pediatric Patients. For further insights on the renal biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the renal biomarkers market?

The renal biomarkers market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases. The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to personalized medicine and targetedTherapies, integration of biomarker testing into routine clinical practice, emerging markets in asia and latin america, non-invasive biomarker testing methods, continuous monitoring with wearable devices. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, ai and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention. For further insights on the renal biomarkers market, request a sample here

How is the renal biomarkers market segmented?

The renal biomarkers market is segmented
1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users Subsegments:
1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate
2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)
3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease BiomarkersFor further insights on the renal biomarkers market, request a sample here

Which region has the largest share of the renal biomarkers market? What are the other regions covered in the report?

North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the renal biomarkers market, request a sample here.

Who are the major players in the renal biomarkers market?

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc. For further insights on the renal biomarkers market, request a sample here.

What are the key trends in the renal biomarkers market?

Major trend in the renal biomarkers market - Innovative Technologies Transforming The Renal Biomarkers Market. For further insights on the renal biomarkers market, request a sample here.

What are the major opportunities in the renal biomarkers market? What are the strategies for the renal biomarkers market?

For detailed insights on the major opportunities and strategies in the renal biomarkers market, request a sample here.

How does the renal biomarkers market relate to the overall economy and other similar markets?

For detailed insights on renal biomarkers market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the renal biomarkers industry?

For detailed insights on the mergers and acquisitions in the renal biomarkers industry, request a sample here.

What are the key dynamics influencing the renal biomarkers market growth? SWOT analysis of the renal biomarkers market.

For detailed insights on the key dynamics influencing the renal biomarkers market growth and SWOT analysis of the renal biomarkers industry, request a sample here.